Skip to content

Drug interactions

Darunavir + Eplerenone

Severity: Major

Darunavir and Eplerenone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Darunavir is usually given with a pharmacokinetic booster (ritonavir or cobicistat) and these are potent CYP3A4 inhibitors. Eplerenone exposure can rise substantially, raising the risk of severe hyperkalemia.

What this interaction means in plain words

Darunavir and Eplerenone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Darunavir belongs to Anti Virals; Eplerenone belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4 reduces eplerenone clearance, particularly with boosted regimens.

What to do

Limit the eplerenone dose as per labeling for moderate or strong CYP3A4 inhibitors, and monitor serum potassium and renal function closely. Consider an alternative agent when a boosted regimen is used.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Darunavir and Eplerenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Darunavir with Eplerenone?

MediHelp rates the interaction as major. Darunavir and Eplerenone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Darunavir is usually given with a pharmacokinetic booster (ritonavir or cobicistat) and these are potent CYP3A4 inhibitors. Eplerenone exposure can rise substantially, raising the risk of severe hyperkalemia.

How serious is the interaction between Darunavir and Eplerenone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit the eplerenone dose as per labeling for moderate or strong CYP3A4 inhibitors, and monitor serum potassium and renal function closely. Consider an alternative agent when a boosted regimen is used.

What other medicines interact with Eplerenone?

MediHelp also lists interactions of Eplerenone with, for example, Amiloride, Atazanavir, Clarithromycin. The full list is on the Eplerenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in